Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Discovery of new role for leukemia gene

Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Så ska skånsk life science dra nytta av Max IV och ESS

Genom ett nytt projekt ska skånska life science-företag få bättre tillgång till de avancerade forskningsanläggningarna Max IV och ESS i Lund.

Norwegian describes scrapie gene

Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.

Danisco first with green emulsifier

A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

Hey Kurt Berndt...

... who is starting up a research center for youths in Saltsjöbaden.

Få life science-företag i tidig fas syntes i internationell branschmedia

Enligt en undersökning saknar hälften av företagen i tidig utveckling exponering i internationell branschmedia.

En ”triumf” och en besvikelse när vaccinresultat meddelas

Nu har de resultat som pekar på en hög skyddseffekt med Pfizers covid-19-vaccin publicerats. Samtidigt meddelar Sanofi/GSK att deras studieresultat inte var vad...

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Fokus Patient blir internationellt

I oktober arrangerar Fokus Patient konferenser i dagarna tre. Fokus ligger i år på internationella samarbeten.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Stort intresse för digitalt möte

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

"Vår nisch är att lösa problem"

Avancerade biologiska läkemedel är finska kontraktstillverkaren Biovians specialitet, och bland kunderna finns flera svenska genterapibolag. – Vi är ganska inri...